Literature DB >> 18828583

Small molecule modulators of toll-like receptors.

Michael Czarniecki1.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18828583     DOI: 10.1021/jm800957k

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  13 in total

1.  Toll-like receptor 4 plays a central role in cardiac dysfunction during trauma hemorrhage shock.

Authors:  Xia Zhang; Chen Lu; Ming Gao; Xinyun Cao; Tuanzhu Ha; John H Kalbfleisch; David L Williams; Chuanfu Li; Race L Kao
Journal:  Shock       Date:  2014-07       Impact factor: 3.454

2.  Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists.

Authors:  Matthew D Morin; Ying Wang; Brian T Jones; Lijing Su; Murali M R P Surakattula; Michael Berger; Hua Huang; Elliot K Beutler; Hong Zhang; Bruce Beutler; Dale L Boger
Journal:  J Med Chem       Date:  2016-04-25       Impact factor: 7.446

Review 3.  Alkynoates as Versatile and Powerful Chemical Tools for the Rapid Assembly of Diverse Heterocycles under Transition-Metal Catalysis: Recent Developments and Challenges.

Authors:  Imtiaz Khan; Aliya Ibrar; Sumera Zaib
Journal:  Top Curr Chem (Cham)       Date:  2021-01-05

4.  Discovery of a novel TLR2 signaling inhibitor with anti-viral activity.

Authors:  Shenghua Zhou; Anna M Cerny; Glennice Bowen; Melvin Chan; David M Knipe; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  Antiviral Res       Date:  2010-07-23       Impact factor: 5.970

5.  Synthesis, structure-activity relationship studies and evaluation of a TLR 3/8/9 agonist and its analogues.

Authors:  Anindya Sarkar; Anushka C Galasiti Kankanamalage; Qian Zhang; Heng Cheng; Prasanna Sivaprakasam; Joseph Naglich; Chunshan Xie; Sanjeev Gangwar; Dale L Boger
Journal:  Med Chem Res       Date:  2021-05-18       Impact factor: 2.351

6.  Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists.

Authors:  Sashi Debnath; Guiyang Hao; Bing Guan; Pawan Thapa; Justin Hao; Hans Hammers; Xiankai Sun
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

7.  Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy.

Authors:  Amanda Shanks Huynh; Woo Jin Chung; Hyun-Il Cho; Valerie E Moberg; Esteban Celis; David L Morse; Josef Vagner
Journal:  J Med Chem       Date:  2012-11-08       Impact factor: 7.446

8.  Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists.

Authors:  Matthew D Morin; Ying Wang; Brian T Jones; Yuto Mifune; Lijing Su; Hexin Shi; Eva Marie Y Moresco; Hong Zhang; Bruce Beutler; Dale L Boger
Journal:  J Am Chem Soc       Date:  2018-10-16       Impact factor: 15.419

9.  Discovery of Imidazoquinolines with Toll-Like Receptor 7/8 Independent Cytokine Induction.

Authors:  Ce Shi; Zhengming Xiong; Padmaja Chittepu; Courtney C Aldrich; John R Ohlfest; David M Ferguson
Journal:  ACS Med Chem Lett       Date:  2012-06-14       Impact factor: 4.345

10.  Design, Synthesis and Structure-Activity Relationship Optimization of Lycorine Derivatives for HCV Inhibition.

Authors:  Duozhi Chen; Jieyun Cai; Junjun Cheng; Chenxu Jing; Junlin Yin; Jiandong Jiang; Zonggen Peng; Xiaojiang Hao
Journal:  Sci Rep       Date:  2015-10-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.